We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+2.03%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$6.75B
AUM Growth
+$227M
Cap. Flow
+$521M
Cap. Flow %
7.72%
Top 10 Hldgs %
24.03%
Holding
181
New
21
Increased
67
Reduced
21
Closed
25

Sector Composition

Rank Sector Weight
1 Healthcare 42.01%
2 Technology 26.2%
3 Industrials 11.22%
4 Consumer Discretionary 7.43%
5 Communication Services 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBAC icon
126
SBA Communications
SBAC
$19.4B
$6.32M 0.09%
22,766
+5,300
+30% +$1.4M
ARE icon
127
Alexandria Real Estate Equities
ARE
$9.11B
$6.29M 0.09%
38,300
+6,000
+19% +$1M
ELS icon
128
Equity Lifestyle Properties
ELS
$11.9B
$6.07M 0.09%
+95,300
New +$5.93M
SLDB icon
129
Solid Biosciences
SLDB
$897M
$5.98M 0.09%
+72,125
New +$7.98M
SYY icon
130
Sysco
SYY
$38.1B
$5.86M 0.09%
74,400
+19,400
+35% +$1.5M
GRMN
131
Garmin
GRMN
$53.8B
$5.64M 0.08%
42,800
+21,900
+105% +$2.73M
MSCI icon
132
MSCI
MSCI
$39.6B
$4.7M 0.07%
11,200
+4,050
+57% +$1.7M
ZTS icon
133
Zoetis
ZTS
$30.3B
$4.5M 0.07%
28,600
+6,400
+29% +$1.01M
NDAQ icon
134
Nasdaq
NDAQ
$49.9B
$3.95M 0.06%
80,400
+24,000
+43% +$1.14M
FOUR icon
135
Shift4
FOUR
$3.34B
$3.79M 0.06%
46,160
+14,300
+45% +$1.11M
CRNX
136
DELISTED
Crinetics Pharmaceuticals
CRNX
$3.69M 0.05%
241,140
-158,860
-40% -$2.46M
OLK
137
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$3.64M 0.05%
+101,000
New +$3.4M
ZBH icon
138
Zimmer Biomet
ZBH
$18.8B
$3.24M 0.05%
20,827
JKHY icon
139
Jack Henry & Associates
JKHY
$10.8B
$2.97M 0.04%
19,600
-20,532
-51% -$3.13M
LSCC icon
140
Lattice Semiconductor
LSCC
$15.1B
$2.63M 0.04%
58,447
+23,503
+67% +$1.04M
NXPI icon
141
NXP Semiconductors
NXPI
$57.1B
$2.4M 0.04%
11,900
-6,300
-35% -$1.15M
AMD icon
142
Advanced Micro Devices
AMD
$823B
$2.38M 0.04%
30,285
+9,761
+48% +$840K
DBTX
143
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$2.27M 0.03%
+200,000
New +$3.14M
SHW icon
144
Sherwin-Williams
SHW
$78.5B
$2.07M 0.03%
8,400
-4,200
-33% -$1M
OM icon
145
Outset Medical
OM
$59M
$1.97M 0.03%
2,416
+667
+38% +$515K
SLAB icon
146
Silicon Laboratories
SLAB
$7.34B
$1.75M 0.03%
12,437
+3,239
+35% +$464K
ETTX
147
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$1.26M 0.02%
590,602
-288,939
-33% -$821K
TTD icon
148
CALL
Trade Desk
TTD
$7.05B
$1.13M 0.02%
+15,000
New +$1.16M
DOCU
149
DocuSign
DOCU
$13.4B
$976K 0.01%
4,819
PAYC icon
150
Paycom
PAYC
$10.2B
$925K 0.01%
+2,500
New +$985K

Similar funds

Eventide Asset Management's Q1 2021 Portfolio in Review

As of Q1 2021, Eventide Asset Management held 181 positions worth $6.75B, up 3.5% from $6.52B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management deployed $521M of net new capital in Q1 2021, opening 21 new positions and adding to 67 existing holdings. Its largest new stake was Prometheus Biosciences, Inc. Common Stock: 3,714,032 shares worth $65.6M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 44% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Wayfair, an estimated $45.9M trimmed.

  • Eventide Asset Management's largest Q1 2021 buy was Prometheus Biosciences, Inc. Common Stock: 3,714,032 shares worth $65.6M.
  • Eventide Asset Management added most to Entegris in Q1 2021, an estimated $55.4M increase.
  • Eventide Asset Management's biggest Q1 2021 reduction was Wayfair, cutting an estimated $45.9M.
  • Eventide Asset Management fully exited Ecolab in Q1 2021, selling an estimated $49.8M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $6.75B portfolio in Q1 2021.
  • Eventide Asset Management opened 21 new positions and closed 25 in Q1 2021.
  • Eventide Asset Management's portfolio value rose 3.5% quarter-over-quarter to $6.75B.

Based on Eventide Asset Management's 13F filing for Q1 2021, filed 14 May 2021.